Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-26-000070

Chief Executive Officer gave up 32,088 shares (to pay taxes)

  • Chief Executive Officer acquired 36,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kelderman Kim · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-14 Exercise or conversion : show line 1 in the form +36,500 85,165 D
2026-04-14 Shares withheld for taxes : show line 2 in the form −32,088 $58.66 $1,882,282 53,077 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-14 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −36,500 73,036 D
Loading xslF345X06/form4.xml…